Showing 1751-1760 of 3391 results for "".
On the Leading Edge, Not the Bleeding Edge: Joe Niamtu, DMD
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/on-the-leading-edge-not-the-bleeding-edge-joe-niamtu-dmd/18606/Innovator, influencer, and podium perennial Joe Niatmu, III, DMD has built a successful surgical aesthetic practice by focusing on the basics, concentrating on his strengths, and avoiding passing fads. How does he stay passionate, spot the best new developments, and build a fulfilling practice? In tDr. Ross Discusses Experience with Gemini Laser
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/dr-ross-discusses-experience-with-gemini-laser/19470/“There are a lot of new technologies out there, but one of the tried-and-true technologies is KTP laser and the long-pulse YAG laser. And the Gemini fits the bill for both of those wavelengths. So in a sense the Gemini is a time-tested product. It has served us well at our clinic, both at the NavyImproving Dermatologic Care and Access for Gender and Sexual Minority Patients
https://practicaldermatology.com/conferences/aad-2021/improving-dermatologic-care-and-access-for-gender-and-sexual-minority-patients/19919/Dermatologists need increased knowledge of health disparities and tools to best meet the needs of sexual and gender minority patients. From increased risk of skin cancer in sexual minority individuals to acne in the transgender population, there are many dermatologic concerns arising for patients, sAbbVie's Skyrizi Approved, Brooke Shields Endorses SculpSure
https://practicaldermatology.com/topics/psoriasis/dermwire-tv-abbvies-skyrizi-approved-brooke-shi/19607/Skyrizi, an interleukin-23 inhibitor from AbbVie, is FDA approved for the treatment of moderate to severe plaque psoriasis in adults. Brooke Shields is the face of the new “Be strong. Be sexy. Be confident” campaign for SculpSure, from Hologic’s Cynosure. The Noah Worcester Dermatological Society anPipeline Watch: Sizing Up a Promising Phase III IL-17 Biologic
https://practicaldermatology.com/topics/psoriasis/pipeline-watch-sizing-up-a-promising-phase-iii-il-17-biologic/21214/Pipeline Watch is a new Q&A feature appearing periodically in Practical Dermatology® that explores the potential of therapeutic agents currently under investigation. In each edition, we will speak with investigators from manufacturing companies to gain insights about the development and investigDealing with Prescription Prior Authorization in Dermatology
https://practicaldermatology.com/topics/practice-management/dealing-with-prescription-prior-authorization-in-dermatology/22079/Complaints and concerns abound, but remedies are slow in coming.Pearls for Management of Steroid-Responsive Dermatoses
https://practicaldermatology.com/topics/general-topics/pearls-for-management-of-steroid-responsive-dermatoses/21958/From side effects to therapeutic combinations to consider, here is an update on the latest approaches to management of steroid-responsive dermatoses.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-34/23707/Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-13/23272/Is Biopsy Effective for BCC on the Head and Neck?; Ask an Expert: Wound Care and Healing
https://practicaldermatology.com/youngmd-connect/resident-resource-center/is-biopsy-effective-for-bcc-on-the-head-and-neck-ask-an-expert-wound-care-and-healing/21141/